Filing Flows › Bio Key International (BKYI) › Q4 2025
Bio Key International (BKYI) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Jun 12, 2026
Bio Key International (BKYI) reported revenue of $1.1M for the fourth quarter 2025 (Q4 2025), -26% from a year earlier and -30% from the quarter before. Operating margin was -388.5%, net loss $4.3M (395.8% of revenue).
Bio Key International, Q4 2025: revenue $1.1M (-26% year over year), operating margin -388.5%, net loss $4.3M, operating cash flow −$1.8M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.1M | -30% | -26% |
| Operating profit | −$4.2M | — | — |
| Net earnings | −$4.3M | — | — |
| Operating cash flow | −$1.8M | — | — |
What changed
Revenue was $1.1M in Q4 2025, down 26% year over year and down 30% from the previous quarter. License was the largest line at 55% of revenue.
Gross margin was 75.0%, down 7.1 points from Q4 2024. Operating costs exceeded revenue by $4.2M, an operating margin of -388.5%. Operating expenses grew 104% against a revenue fall of 26%. The quarter ended with a net loss of $4.3M, wider than the previous quarter's $1.0M loss.
Operating cash flow was −$1.8M. Non-cash charges added back $76K of depreciation and amortization and $61K of share-based compensation. Working capital and other items added $2.3M. Capital expenditures of $5K exceeded it, leaving free cash flow of −$1.8M.
Questions
What was Bio Key International's revenue in the fourth quarter 2025?
Bio Key International (BKYI) reported revenue of $1.1M for the fourth quarter 2025 (Q4 2025), -26% from a year earlier and -30% from the quarter before.
Was Bio Key International profitable in the fourth quarter 2025?
Operating loss was $4.2M (-388.5% of revenue) and net loss $4.3M.